7 results on '"Catalano, Onofrio"'
Search Results
2. The role of FDG PET/CT radiomics in the prediction of pathological response to neoadjuvant treatment in patients with esophageal cancer.
- Author
-
Eifer, Michal, Peters-Founshtein, Gregory, Yoel, Lotem Cohn, Pinian, Hodaya, Steiner, Roee, Klang, Eyal, Catalano, Onofrio A., Eshet, Yael, and Domachevsky, Liran
- Abstract
Background: Attainment of a complete histopathological response following neoadjuvant therapy has been associated with favorable long-term survival outcomes in esophageal cancer patients. We investigated the ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) radiomic features to predict the pathological response to neoadjuvant treatment in patients with esophageal cancer. Materials and methods: A retrospective review of medical records of patients with locally advanced resectable esophageal or esophagogastric junctional cancers. Included patients had a baseline FDG PET/CT scan and underwent Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) protocol followed by surgery. Four demographic variables and 107 PET radiomic features were extracted and analyzed using univariate and multivariate analyses to predict response to neoadjuvant therapy. Results: Overall, 53 FDG-avid primary esophageal cancer lesions were segmented and radiomic features were extracted. Seventeen radiomic features and 2 non-radiomics variables were found to exhibit significant differences between neoadjuvant therapy responders and non-responders. An unsupervised hierarchical clustering analysis using these 19 variables classified patients in a manner significantly associated with response to neoadjuvant treatment (p < 0.01). Conclusion: Our findings highlight the potential of FDG PET/CT radiomic features as a predictor for the response to neoadjuvant therapy in esophageal cancer patients. The combination of these radiomic features with select non-radiomic variables provides a model for stratifying patients based on their likelihood to respond to neoadjuvant treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma.
- Author
-
Wei, Jingwei, Jiang, Hanyu, Zhou, Yu, Tian, Jie, Furtado, Felipe S., and Catalano, Onofrio A.
- Abstract
The high postoperative recurrence rates in hepatocellular carcinoma (HCC) remain a major hurdle in its management. Appropriate staging and treatment selection may alleviate the extent of fatal recurrence. However, effective methods to preoperatively evaluate pathophysiologic and molecular characteristics of HCC are lacking. Imaging plays a central role in HCC diagnosis and stratification due to the non-invasive diagnostic criteria. Vast and crucial information is hidden within image data. Other than providing a morphological sketch for lesion diagnosis, imaging could provide new insights to describe the pathophysiological and genetic landscape of HCC. Radiomics aims to facilitate diagnosis and prognosis of HCC using artificial intelligence techniques to harness the immense information contained in medical images. Radiomics produces a set of archetypal and robust imaging features that are correlated to key pathological or molecular biomarkers to preoperatively risk-stratify HCC patients. Inferred with outcome data, comprehensive combination of radiomic, clinical and/or multi-omics data could also improve direct prediction of response to treatment and prognosis. The evolution of radiomics is changing our understanding of personalized precision medicine in HCC management. Herein, we review the key techniques and clinical applications in HCC radiomics and discuss current limitations and future opportunities to improve clinical decision making. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Multiparametric 18 F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Author
-
Umutlu, Lale, Kirchner, Julian, Bruckmann, Nils-Martin, Morawitz, Janna, Antoch, Gerald, Ting, Saskia, Bittner, Ann-Kathrin, Hoffmann, Oliver, Häberle, Lena, Ruckhäberle, Eugen, Catalano, Onofrio Antonio, Chodyla, Michal, Grueneisen, Johannes, Quick, Harald H., Fendler, Wolfgang P., Rischpler, Christoph, Herrmann, Ken, Gibbs, Peter, and Pinker, Katja
- Subjects
BREAST tumor treatment ,PREDICTIVE tests ,CANCER chemotherapy ,CLASSIFICATION ,MAGNETIC resonance imaging ,PATIENTS ,RETROSPECTIVE studies ,TREATMENT effectiveness ,RADIOPHARMACEUTICALS ,POSITRON emission tomography ,DEOXY sugars ,COMBINED modality therapy ,SENSITIVITY & specificity (Statistics) ,EVALUATION - Abstract
Simple Summary: In breast cancer, the leading cancer type and the main cause of cancer death in women, achieving pathological complete response after neoadjuvant chemotherapy has been shown to be associated with prolonged overall survival. Hence, the correct assessment and the potential prediction of therapy response have recently become the focus of research. In this study, we predicted pathological complete response prior to neoadjuvant system therapy using
18 F-FDG PET/MRI radiomics analysis of the breast. Hence, simultaneous18 F-FDG PET/MRI may enable a more individualized and targeted approach to treatment as well as pretherapeutic patient stratification. Background: The aim of this study was to assess whether multiparametric18 F-FDG PET/MRI-based radiomics analysis is able to predict pathological complete response in breast cancer patients and hence potentially enhance pretherapeutic patient stratification. Methods: A total of 73 female patients (mean age 49 years; range 27–77 years) with newly diagnosed, therapy-naive breast cancer underwent simultaneous18 F-FDG PET/MRI and were included in this retrospective study. All PET/MRI datasets were imported to dedicated software (ITK-SNAP v. 3.6.0) for lesion annotation using a semi-automated method. Pretreatment biopsy specimens were used to determine tumor histology, tumor and nuclear grades, and immunohistochemical status. Histopathological results from surgical tumor specimens were used as the reference standard to distinguish between complete pathological response (pCR) and noncomplete pathological response. An elastic net was employed to select the most important radiomic features prior to model development. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for each model. Results: The best results in terms of AUCs and NPV for predicting complete pathological response in the entire cohort were obtained by the combination of all MR sequences and PET (0.8 and 79.5%, respectively), and no significant differences from the other models were observed. In further subgroup analyses, combining all MR and PET data, the best AUC (0.94) for predicting complete pathologic response was obtained in the HR+/HER2− group. No difference between results with/without the inclusion of PET characteristics was observed in the TN/HER2+ group, each leading to an AUC of 0.92 for all MR and all MR + PET datasets. Conclusion:18 F-FDG PET/MRI enables comprehensive high-quality radiomics analysis for the prediction of pCR in breast cancer patients, especially in those with HR+/HER2− receptor status. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
5. Editorial for "A Multicenter Study on Preoperative Assessment of Lymphovascular Space Invasion in Early‐Stage Cervical Cancer Based on Multimodal MR Radiomics".
- Author
-
Furtado, Felipe S. and Catalano, Onofrio A.
- Subjects
RADIOMICS ,CERVICAL cancer ,MACHINE learning ,COMPUTER-aided diagnosis ,GENITAL warts - Abstract
5 Lee SI, Atri M. 2018 FIGO staging system for uterine cervical cancer: Enter cross-sectional imaging. Editorial for "A Multicenter Study on Preoperative Assessment of Lymphovascular Space Invasion in Early-Stage Cervical Cancer Based on Multimodal MR Radiomics" Cervical cancer is a prevalent disease responsible for a substantial burden, being the fourth most common cancer in women globally.[1] Although established primary and secondary prevention practices exist with human papillomavirus (HPV) vaccination and Papanicolaou smear screening, respectively, this disease is predicted to claim 13,960 lives in the United States alone in 2023.[2] Moreover, significant disparities persist. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
6. Publisher Correction to: PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features.
- Author
-
Esfahani, Shadi A., Torrado-Carvajal, Angel, Amorim, Barbara Juarez, Groshar, David, Domachevsky, Liran, Bernstine, Hanna, Stein, Dan, Gervais, Debra, and Catalano, Onofrio A.
- Subjects
RADIOMICS ,COMPUTED tomography ,CERVICAL cancer ,MAGNETIC resonance imaging ,POSITRON emission tomography computed tomography ,PILOT projects ,PELVIC radiography ,DIAGNOSTIC imaging ,CERVIX uteri tumors ,TUMOR grading - Abstract
Publisher Correction to: PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features B Correction to: Molecular Imaging and Biology b https://doi.org/10.1007/s11307-021-01658-1 This article was updated to include the statement "Shadi A. Esfahani and Angel Torrado-Carvajal contributed equally to this manuscript." Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
7. Fully Automated MR Based Virtual Biopsy of Cerebral Gliomas.
- Author
-
Haubold, Johannes, Hosch, René, Parmar, Vicky, Glas, Martin, Guberina, Nika, Catalano, Onofrio Antonio, Pierscianek, Daniela, Wrede, Karsten, Deuschl, Cornelius, Forsting, Michael, Nensa, Felix, Flaschel, Nils, and Umutlu, Lale
- Subjects
BRAIN tumor diagnosis ,BIOPSY ,RADIOGRAPHY ,PREDICTIVE tests ,GLIOMAS ,TISSUES ,BRAIN ,MAGNETIC resonance imaging ,TUMOR grading ,LONGITUDINAL method ,WORKFLOW ,GENE expression ,AUTOMATION ,COLLECTION & preservation of biological specimens ,GENETIC mutation ,BRAIN tumors - Abstract
Simple Summary: Over the past few years, radiomics-based tissue characterization has demonstrated its potential for non-invasive prediction of the genetic profile and grading in cerebral gliomas using multiparametric MRI. The aim of our study was to investigate the feasibility and diagnostic accuracy of a fully automated radiomics analysis based on a simplified MR protocol derived from various scanner systems to prospectively ease the transition of radiomics-based non-invasive tissue sampling into clinical practice. Using an MRI with non-contrast and post-contrast T1-weighted sequences and FLAIR, our workflow automatically predicts the IDH1/2 mutation, the ATRX expression loss, the 1p19q co-deletion and the MGMT methylation status. It also effectively differentiates low-grade from high-grade gliomas. In summary, the present study demonstrated that a fully automated prediction of grading and the genetic profile of cerebral gliomas could be performed with our proposed method using a simplified MRI protocol that is robust to variations in scanner systems, imaging parameters and field strength. Objective: The aim of this study was to investigate the diagnostic accuracy of a radiomics analysis based on a fully automated segmentation and a simplified and robust MR imaging protocol to provide a comprehensive analysis of the genetic profile and grading of cerebral gliomas for everyday clinical use. Methods: MRI examinations of 217 therapy-naïve patients with cerebral gliomas, each comprising a non-contrast T1-weighted, FLAIR and contrast-enhanced T1-weighted sequence, were included in the study. In addition, clinical and laboratory parameters were incorporated into the analysis. The BraTS 2019 pretrained DeepMedic network was used for automated segmentation. The segmentations generated by DeepMedic were evaluated with 200 manual segmentations with a DICE score of 0.8082 ± 0.1321. Subsequently, the radiomics signatures were utilized to predict the genetic profile of ATRX, IDH1/2, MGMT and 1p19q co-deletion, as well as differentiating low-grade glioma from high-grade glioma. Results: The network provided an AUC (validation/test) for the differentiation between low-grade gliomas vs. high-grade gliomas of 0.981 ± 0.015/0.885 ± 0.02. The best results were achieved for the prediction of the ATRX expression loss with AUCs of 0.979 ± 0.028/0.923 ± 0.045, followed by 0.929 ± 0.042/0.861 ± 0.023 for the prediction of IDH1/2. The prediction of 1p19q and MGMT achieved moderate results, with AUCs of 0.999 ± 0.005/0.711 ± 0.128 for 1p19q and 0.854 ± 0.046/0.742 ± 0.050 for MGMT. Conclusion: This fully automated approach utilizing simplified MR protocols to predict the genetic profile and grading of cerebral gliomas provides an easy and efficient method for non-invasive tumor decoding. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.